期刊
CANCER CHEMOTHERAPY AND PHARMACOLOGY
卷 84, 期 2, 页码 415-425出版社
SPRINGER
DOI: 10.1007/s00280-019-03892-5
关键词
Glioma; Glioblastoma; Chemoresistance; Epithelial-to-mesenchymal transition; TGF beta; SMAD3
资金
- China National Nature and Science Foundation [81472355]
PurposeGlioblastoma is the most malignant glioma tumors with inevitable relapse and resistance to chemotherapy; however, the mechanisms driving chemoresistance remain to be fully elucidated. This study is to explore the molecular and cellular mechanisms involving in the chemoresistance of glioblastoma.MethodsThe expression of musashi (MSI) RNA-binding protein in the tumor tissues and cells of glioblastoma was measured. The effects of MSI2 in epithelial-to-mesenchymal transition (EMT), resistance to temozolomide (TMZ), tumor cell invasion, migration, and proliferation and associated signaling were evaluated.ResultsHigh MSI2 expression was observed in the glioblastoma tissues. Silencing or overexpression of MSI2 significantly affected tumor cells invasion, migration, and proliferation. Silencing of MSI2 expression significantly inhibited O-6-methylguanine-DNA methyltransferase (MGMT) expression and tumor growth, and reversed resistance to TMZ in xenograft tumor models. MSI2 expression regulated EMT through activating the transcription factors Snail and the TGF beta R1/SMAD3 signaling.ConclusionsOur study demonstrated a positive feedback loop of MSI2-TGF beta/SMAD3 signaling which activates the EMT and MGMT which may contribute to chemoresistance in glioblastoma. This study also highlights that MSI2 could be a new target for the therapy of glioblastoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据